CytoDyn (STU:296) 3-Year EBITDA Growth Rate : 38.50% (As of Feb. 2025)

View and export this data going back to 2016. Start your Free Trial

What is CytoDyn 3-Year EBITDA Growth Rate?

CytoDyn's EBITDA per Share for the three months ended in Feb. 2025 was €-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 38.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 25.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 9.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of CytoDyn was 38.50% per year. The lowest was -57.00% per year. And the median was 2.65% per year.

Competitive Comparison of CytoDyn's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, CytoDyn's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CytoDyn's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CytoDyn's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where CytoDyn's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

CytoDyn 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

CytoDyn (STU:296) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

CytoDyn 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of CytoDyn's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

CytoDyn Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CytoDyn Inc (STU:296) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

CYDY:USA

Address

1111 Main Street, Suite 660, Vancouver, WA, USA, 98660

Website

https://www.cytodyn.com

CytoDyn Inc is a USA-based clinical-stage biotechnology company that focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The product candidate is PRO 140, which is a class of HIV therapy called entry inhibitors that block HIV from entering into and infecting certain cells. The company emphasizes exploring opportunities for clinical applications for PRO 140 involving the CCR5 (C-C chemokine receptor type 5) receptor, other than HIV-related treatments, such as inflammatory conditions, autoimmune diseases, and cancer.

CytoDyn Headlines

No Headlines